Craig-Hallum Begins Coverage of CDx Firm Celcuity
Celcuity's companion diagnostic platform CELsignia identifies cellular signals corresponding to drug response using a patient's living tumor cells.
Bio-Rad Clinical ddPCR Test, Diagnostic System Get FDA Clearance
The test is for monitoring treatment response in chronic myeloid leukemia and uses a new Droplet Digital PCR instrument.
MolecularMD, Genoptix Ink Marketing Agreement for CDx to Novartis CML Drug
The companion diagnostic test identifies patients taking the Novartis drug Tasigna who are candidates for treatment-free remission monitoring.
MolecularMD Gets FDA Authorization for Companion Dx to Novartis CML Drug
The test measures minimal residual disease and can be used to monitor patients eligible for discontinuation of treatment with Tasigna.